Overcoming ocular drug delivery barriers through the use of physical forces
- PMID: 28916492
- DOI: 10.1016/j.addr.2017.09.008
Overcoming ocular drug delivery barriers through the use of physical forces
Erratum in
-
Corrigendum to "Overcoming ocular drug delivery barriers through the use of physical forces" [Advanced Drug Delivery Reviews 126 (2018) 96-112].Adv Drug Deliv Rev. 2019 Jan 15;139:157. doi: 10.1016/j.addr.2019.05.006. Epub 2019 May 24. Adv Drug Deliv Rev. 2019. PMID: 31133328 No abstract available.
Abstract
Overcoming the physiological barriers in the eye remains a key obstacle in the field of ocular drug delivery. While ocular barriers naturally have a protective function, they also limit drug entry into the eye. Various pharmaceutical strategies, such as novel formulations and physical force-based techniques, have been investigated to weaken these barriers and transport therapeutic agents effectively to both the anterior and the posterior segments of the eye. This review summarizes and discusses the recent research progress in the field of ocular drug delivery with a focus on the application of physical methods, including electrical fields, sonophoresis, and microneedles, which can enhance penetration efficiency by transiently disrupting the ocular barriers in a minimally or non-invasive manner.
Keywords: Electrical fields; Electroporation; Iontophoresis; Microneedles; Ocular drug delivery; Physiological barriers; Sonophoresis.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Ocular Drug Delivery.Handb Exp Pharmacol. 2017;242:57-93. doi: 10.1007/164_2016_84. Handb Exp Pharmacol. 2017. PMID: 27783270
-
Dendrimers as a promising tool in ocular therapeutics: Latest advances and perspectives.Int J Pharm. 2016 Sep 10;511(1):359-366. doi: 10.1016/j.ijpharm.2016.07.031. Epub 2016 Jul 18. Int J Pharm. 2016. PMID: 27436708 Review.
-
Targeted Nanotherapies for the Posterior Segment of the Eye: An Integrative Review on Recent Advancements and Challenges.Pharm Nanotechnol. 2022 Nov 15;10(4):268-278. doi: 10.2174/2211738510666220806102612. Pharm Nanotechnol. 2022. PMID: 35946098 Review.
-
Non-invasive strategies for targeting the posterior segment of eye.Int J Pharm. 2017 Sep 15;530(1-2):326-345. doi: 10.1016/j.ijpharm.2017.07.065. Epub 2017 Jul 26. Int J Pharm. 2017. PMID: 28755994 Review.
-
In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye.Adv Drug Deliv Rev. 2018 Feb 15;126:44-57. doi: 10.1016/j.addr.2017.09.007. Epub 2017 Sep 19. Adv Drug Deliv Rev. 2018. PMID: 28939376 Review.
Cited by
-
Antimicrobial nanomedicine for ocular bacterial and fungal infection.Drug Deliv Transl Res. 2021 Aug;11(4):1352-1375. doi: 10.1007/s13346-021-00966-x. Epub 2021 Apr 11. Drug Deliv Transl Res. 2021. PMID: 33840082 Review.
-
Recent Advances in Bioinspired Hydrogels: Materials, Devices, and Biosignal Computing.ACS Biomater Sci Eng. 2023 May 8;9(5):2048-2069. doi: 10.1021/acsbiomaterials.1c00741. Epub 2021 Nov 16. ACS Biomater Sci Eng. 2023. PMID: 34784170 Free PMC article. Review.
-
Breaking Barriers: Nanomedicine-Based Drug Delivery for Cataract Treatment.Int J Nanomedicine. 2024 May 6;19:4021-4040. doi: 10.2147/IJN.S463679. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38736657 Free PMC article. Review.
-
Microneedle-based ocular drug delivery systems - recent advances and challenges.Beilstein J Nanotechnol. 2022 Oct 24;13:1167-1184. doi: 10.3762/bjnano.13.98. eCollection 2022. Beilstein J Nanotechnol. 2022. PMID: 36348935 Free PMC article. Review.
-
Developments in Emerging Topical Drug Delivery Systems for Ocular Disorders.Curr Drug Res Rev. 2024;16(3):251-267. doi: 10.2174/0125899775266634231213044704. Curr Drug Res Rev. 2024. PMID: 38158868 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical